Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -21.38%1.03B | ---- | 134.42%1.31B | ---- | -38.29%558.73M | ---- | -1.69%905.4M | ---- | 4.26%920.92M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -66.65%-29.31M | ---- | -31.81%-17.59M | ---- | 46.25%-13.34M | ---- | 60.55%-24.82M | ---- | 9.49%-62.93M |
| Dividend (income)- adjustment | ---- | -0.65%-28.94M | ---- | -8.40%-28.75M | ---- | 16.53%-26.53M | ---- | -25.21%-31.78M | ---- | 1.56%-25.38M |
| Impairment and provisions: | ---- | -1.19%48.59M | ---- | 3,141.31%49.18M | ---- | -100.98%-1.62M | ---- | -38.67%164.29M | ---- | -43.75%267.89M |
| -Impairment of property, plant and equipment (reversal) | ---- | --2.67M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.06M |
| -Impairmen of inventory (reversal) | ---- | 445.09%70.58M | ---- | 110.57%12.95M | ---- | -42.32%6.15M | ---- | -63.49%10.66M | ---- | 147.65%29.2M |
| -Impairment of trade receivables (reversal) | ---- | -205.84%-38.35M | ---- | 566.52%36.23M | ---- | -105.05%-7.77M | ---- | 136.15%153.63M | ---- | -85.99%65.06M |
| -Other impairments and provisions | ---- | --13.7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --169.57M |
| Revaluation surplus: | ---- | 64.08%800.21M | ---- | 94.65%487.7M | ---- | 927.24%250.55M | ---- | -114.93%-30.29M | ---- | -9.68%202.83M |
| -Fair value of investment properties (increase) | ---- | 318.16%16.95M | ---- | 14,575.00%4.05M | ---- | 97.95%-28K | ---- | -175.32%-1.36M | ---- | 186.73%1.81M |
| -Derivative financial instruments fair value (increase) | ---- | 92.03%-636K | ---- | 14.06%-7.98M | ---- | -287.67%-9.28M | ---- | 352.27%4.95M | ---- | -184.49%-1.96M |
| -Other fair value changes | ---- | 59.45%783.9M | ---- | 89.18%491.62M | ---- | 867.22%259.87M | ---- | -116.69%-33.87M | ---- | -9.52%202.98M |
| Asset sale loss (gain): | ---- | 134.08%82.68M | ---- | 708.04%35.32M | ---- | 62.24%-5.81M | ---- | -158.43%-15.38M | ---- | -79.37%26.33M |
| -Available for sale investment sale loss (gain) | ---- | 110.29%71.23M | ---- | 372.79%33.87M | ---- | 39.16%-12.42M | ---- | -195.16%-20.41M | ---- | -82.60%21.45M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 55.82%11.45M | ---- | 11.26%7.35M | ---- | 31.48%6.61M | ---- | 2.97%5.03M | ---- | 11.06%4.88M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---5.9M | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 2.91%964.44M | ---- | 7.64%937.13M | ---- | 6.67%870.58M | ---- | -12.45%816.14M | ---- | 1.20%932.2M |
| -Depreciation | ---- | -2.31%338.7M | ---- | 4.02%346.72M | ---- | 7.29%333.31M | ---- | 11.79%310.65M | ---- | 17.88%277.89M |
| Financial expense | ---- | 7.82%140.05M | ---- | 58.68%129.9M | ---- | 28.81%81.86M | ---- | -27.67%63.55M | ---- | -1.46%87.86M |
| Special items | ---- | -93.05%-13.3M | ---- | 64.55%-6.89M | ---- | 7.55%-19.43M | ---- | 72.21%-21.02M | ---- | ---75.64M |
| Operating profit before the change of operating capital | ---- | 3.40%2.99B | ---- | 70.84%2.9B | ---- | -7.18%1.69B | ---- | -19.70%1.83B | ---- | -13.42%2.27B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -164.05%-771.71M | ---- | 74.87%-292.26M | ---- | 52.39%-1.16B | ---- | -805.79%-2.44B | ---- | 122.30%346.01M |
| Accounts receivable (increase)decrease | ---- | 167.50%129.97M | ---- | -70.94%-192.55M | ---- | -126.36%-112.64M | ---- | 270.74%427.37M | ---- | 109.72%115.27M |
| Accounts payable increase (decrease) | ---- | -30,000.62%-192.26M | ---- | 100.35%643K | ---- | 55.65%-185.48M | ---- | -532.27%-418.25M | ---- | 98.93%96.76M |
| prepayments (increase)decrease | ---- | -171.68%-134.82M | ---- | -59.25%-49.62M | ---- | 89.63%-31.16M | ---- | -470.69%-300.48M | ---- | 59.53%-52.65M |
| Derivative financial instruments (increase) decrease | ---- | -198.49%-71.23M | ---- | -292.19%-23.86M | ---- | -39.16%12.42M | ---- | 195.16%20.41M | ---- | 82.60%-21.45M |
| Special items for working capital changes | ---- | -89.50%167K | ---- | -12.34%1.59M | ---- | -99.62%1.82M | ---- | 402.75%481.4M | ---- | -1,049.34%-159.01M |
| Cash from business operations | ---- | -16.47%1.95B | ---- | 977.57%2.34B | ---- | 153.54%217.13M | ---- | -115.60%-405.57M | ---- | 185.16%2.6B |
| Hong Kong profits tax paid | ---- | -1,210.21%-114.97M | ---- | -232.26%-8.78M | ---- | 71.78%-2.64M | ---- | 85.43%-9.36M | ---- | -81.60%-64.22M |
| China income tax paid | ---- | 75.44%-35M | ---- | 7.27%-142.54M | ---- | 47.06%-153.72M | ---- | -16.03%-290.36M | ---- | -15.87%-250.24M |
| Other taxs | ---- | -124.03%-9.08M | ---- | ---4.05M | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest received - operating | ---- | 62.29%29.01M | ---- | 37.46%17.88M | ---- | -47.69%13.01M | ---- | -60.95%24.86M | ---- | -8.60%63.67M |
| Interest paid - operating | ---- | -14.09%-48.19M | ---- | -4.60%-42.24M | ---- | 9.75%-40.38M | ---- | 22.81%-44.74M | ---- | 0.48%-57.96M |
| Special items of business | -24.78%1.17B | ---- | -2.58%1.56B | ---- | 114.69%1.6B | ---- | 1,326.65%746.69M | ---- | -97.57%52.34M | ---- |
| Net cash from operations | -24.78%1.17B | -17.77%1.78B | -2.58%1.56B | 6,367.59%2.16B | 114.69%1.6B | 104.61%33.4M | 1,326.65%746.69M | -131.66%-725.16M | -97.57%52.34M | 241.06%2.29B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 23.82%16.93M | 0.65%28.94M | 5.49%13.67M | 8.40%28.75M | -10.54%12.96M | -16.53%26.53M | -5.63%14.49M | 25.21%31.78M | 36.19%15.35M | -1.56%25.38M |
| Sale of fixed assets | -70.46%70K | 841.46%772K | 82.31%237K | -85.41%82K | 233.33%130K | -45.28%562K | -58.95%39K | 43.64%1.03M | --95K | 156.27%715K |
| Purchase of fixed assets | 56.98%-43.95M | 50.91%-214.77M | 64.24%-102.16M | -15.40%-437.52M | -89.90%-285.7M | 4.40%-379.13M | -33.03%-150.45M | -68.15%-396.59M | -26.06%-113.09M | 43.19%-235.85M |
| Purchase of intangible assets | 14.16%-11.52M | 52.49%-18.38M | 49.77%-13.42M | -42.08%-38.68M | -80.99%-26.72M | 47.36%-27.22M | 41.81%-14.76M | -146.19%-51.71M | -688.59%-25.37M | -137.83%-21.01M |
| Recovery of cash from investments | ---- | ---- | ---- | --23M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | 33.26%-10.79M | ---11.81M | 24.03%-16.17M | ---- | ---21.29M | ---- | ---- |
| Other items in the investment business | -35.02%11.04M | 8.45%28.29M | -0.54%16.99M | -45.66%26.08M | -9.30%17.08M | 34.78%48M | 48.21%18.84M | -70.53%35.61M | --12.71M | --120.83M |
| Net cash from investment operations | 67.60%-27.43M | 57.18%-175.15M | 71.20%-84.68M | -17.74%-409.07M | -123.02%-294.06M | 13.39%-347.44M | -19.52%-131.85M | -264.92%-401.18M | -48.80%-110.31M | 72.37%-109.94M |
| Net cash before financing | -22.32%1.15B | -8.56%1.6B | 12.83%1.48B | 657.54%1.75B | 112.90%1.31B | 72.12%-314.04M | 1,160.55%614.84M | -151.66%-1.13B | -102.79%-57.97M | 696.99%2.18B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -2.10%2.76B | 15.16%6.2B | -24.70%2.82B | -32.11%5.39B | 27.03%3.74B | 20.09%7.94B | 44.66%2.95B | -1.28%6.61B | -15.67%2.04B | 49.66%6.69B |
| Refund | -0.72%-3.39B | -9.59%-6.46B | 18.10%-3.37B | 11.29%-5.89B | -46.07%-4.11B | -21.46%-6.64B | -55.82%-2.81B | 27.36%-5.47B | 43.12%-1.81B | -91.56%-7.53B |
| Interest paid - financing | 7.89%-42.59M | -5.75%-91.57M | -8.46%-46.24M | -127.28%-86.6M | -238.50%-42.63M | -104.59%-38.1M | -28.12%-12.6M | 40.67%-18.62M | 44.46%-9.83M | -2.47%-31.39M |
| Dividends paid - financing | 10.76%-241.82M | -57.14%-372.59M | -166.67%-270.97M | 18.60%-237.1M | 46.43%-101.62M | 23.21%-291.3M | 33.33%-189.68M | -86.67%-379.36M | -68.00%-284.52M | 48.28%-203.23M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --480K | --240K | ---- |
| Issuance expenses and redemption of securities expenses | ---6.55M | ---30.46M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -2.22%-1.18B | 3.94%-1.34B | -50.10%-1.16B | -432.60%-1.39B | -117.38%-771.5M | 212.83%417.98M | 7.06%-354.91M | 108.30%133.61M | 68.67%-381.86M | -199.73%-1.61B |
| Effect of rate | 230.96%21.21M | -95.58%-25.82M | 42.80%-16.19M | 50.85%-13.2M | -36.75%-28.31M | -355.60%-26.86M | -380.16%-20.7M | -81.03%10.51M | 132.19%7.39M | 626.47%55.41M |
| Net Cash | -111.46%-36.56M | -26.40%265.5M | -40.67%318.92M | 247.05%360.72M | 106.78%537.5M | 110.47%103.94M | 159.10%259.93M | -274.15%-992.73M | -151.20%-439.83M | 316.19%570.04M |
| Begining period cash | 21.87%1.34B | 46.42%1.1B | 46.42%1.1B | 11.48%748.63M | 11.48%748.63M | -59.39%671.55M | -59.39%671.55M | 60.82%1.65B | 60.82%1.65B | -21.05%1.03B |
| Cash at the end | -5.60%1.32B | 21.87%1.34B | 11.21%1.4B | 46.42%1.1B | 38.10%1.26B | 11.48%748.63M | -25.43%910.78M | -59.39%671.55M | -34.50%1.22B | 60.82%1.65B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | 5.91%1.2B | 13.62%1.21B | -3.77%1.13B | 46.61%1.07B | 34.10%1.17B | 8.28%727.17M | -27.36%875.63M | -58.02%671.55M | -34.98%1.21B | 77.63%1.6B |
| Cash and cash equivalent balance | 5.91%1.2B | 13.62%1.21B | -3.77%1.13B | 46.61%1.07B | 34.10%1.17B | 8.28%727.17M | -27.36%875.63M | -58.02%671.55M | -34.98%1.21B | 77.63%1.6B |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.